Timeline
BSF Enterprise says 'T-Rex' handbag validated engineering platform
Istesso starts Phase 2 trial of leramistat in sarcopenia
Health & Bio Today: AstraZeneca's Truqap wins FDA approval for prostate cancer
Fusion Antibodies wins InnovateUK grant to humanise DR5 antibody
4basebio appoints Dr Jeff Coller to Strategic Advisory Board
Health & Bio Today: BSF Enterprise shares halve after T-Rex handbag fails at auction, Cizzle Biotechnology, GSK
Cizzle Biotechnology Holdings shares up on US patent grant
BSF Enterprise shares plunge after T‑Rex handbag fails at auction
GSK wins orphan drug status in US and Europe for momelotinib in rare inflammatory blood disorder with no approved treatments
Poolbeg activates first site for POLB 001 TOPICAL trial
Vivoryon says cash will fund operations into Q4 2026 as it pushes varoglutamstat toward Phase 2b in DKD
Poolbeg presents POLB 001 preclinical data showing CRS reduction and potential AML benefit
Health & Bio Today: GSK acquires Nuvalent for $10.6bn, Imaging Biometrics, Seaport Therapeutics, Smith+Nephew
PureTech's Seaport advances GlyphAgo into Phase 2 after positive Phase 1 multiple‑dose data
Imaging Biometrics publishes Phase 1 gallium trial and reopens access programme
The Premarket Brief: LBG Media cuts earnings guidance on Meta algorithm hit, Vantiva HomeSight, Imaging Biometrics, GSK, Keller
GSK to buy Nuvalent for $10.6bn to add late‑stage lung‑cancer drugs
Health & Bio Today: SkinBioTherapeutics restates FY25 after fabricated royalty, Verici Dx, Coiled Therapeutics
Small Caps Today: Verici Dx, Neo Energy Metals, Brickability, Beeks, SkinBio Therapeutics ...
SkinBioTherapeutics restates FY25 after £0.77m fabricated royalty, HY26 revenue up 37%
Coiled Therapeutics appoints Professor Ozgur Sahin as Scientific Advisor
GENinCode targets smaller losses and revenue growth in 2026 as US adoption accelerates
Aptamer Group launches Gates Foundation‑backed programme to build rapid folate test
Health & Bio Today: Imaging Biometrics study validates survival link, genedrive, Agronomics, Verici Dx
genedrive shares surged after R&D tax credit
Verici Dx to raise £2.5m for commercial scale-up
Small Caps Today: Touchstone Exploration, Imaging Biometrics, Iofina, BTG Consulting, Image Scan and more
Avacta Group raises £9m to repay debt
Agronomics' dog food investee boosted by FDA clearance
Health & Bio Today: Incanthera acquires Énielle skincare brand, Crism Therapeutics, Eco Animal Health
Incanthera shares rocket on Énielle acquisition
CRISM Therapeutics lands UK grant for Phase 2 glioblastoma trial
The Premarket Brief: CMC Markets income targets, CRISM grant boost, Helium One, Safestay, S4 Capital, Angus Energy, and more
Health & Bio Today: Imaging Biometrics launches IB Nimble 2 on profitability track, Novo Nordisk
BSF Enterprise raises £500,000 in conditional placing
Health & Bio Today: ValiRx walks away from Stingray licence, Verici Dx, Inspiration Healthcare, Hammerson
BSF Enterprise white paper sets out commercial case for T‑Rex Leather
ValiRx shares tumbled after Stingray evaluation ends
Oxford Biomedica's investor day can kick of a rerating and reignite sentiments
Itaconix forecasts a record first half after a strong FY2025
Health & Bio Today: Avacta reports positive salivary gland cancer data, hVIVO, ValiRx, CRISM Therapeutics, ProBiotix Health
hVIVO signs consultancy deal with Decoy Therapeutics to advance multi‑virus antivirals
Itaconix shares surge after US field trials
Avacta reports positive results in salivary gland cancer research
CRISM Therapeutics lands Northern Ireland grant for ChemoSeed prostate programme
ValiRx exercises RNA option after evaluation finishes four months early
Health & Bio Today: CelLBxHealth wins AstraZeneca services deal, Avacta Group, AstraZeneca
Itaconix shares climbs as it enters partnership for plant-based paint products
CelLBxHealth shares rocket on AstraZeneca master services agreement
More in Healthcare
Genedrive's personalised medicine receives Parliament boost
A government minister named Genedrive's newborn hearing-loss test as a live example of personalised medicine during a House of Commons committee session.